Healthcare Global Enterprises Limited (HCG) - Net Assets

Latest as of March 2026: Rs14.10 Billion INR ≈ $152.51 Million USD

Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has net assets worth Rs14.10 Billion INR (≈ $152.51 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs39.23 Billion ≈ $424.21 Million USD) and total liabilities (Rs25.12 Billion ≈ $271.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Healthcare Global Enterprises Limited (HCG) tangible net worth to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs14.10 Billion
% of Total Assets	35.95%
Annual Growth Rate	14.86%
5-Year Change	59.58%
10-Year Change	187.73%
Growth Volatility	36.31

Healthcare Global Enterprises Limited - Net Assets Trend (2011–2026)

This chart illustrates how Healthcare Global Enterprises Limited's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Healthcare Global Enterprises Limited to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Healthcare Global Enterprises Limited (2011–2026)

The table below shows the annual net assets of Healthcare Global Enterprises Limited from 2011 to 2026. For live valuation and market cap data, see market cap of Healthcare Global Enterprises Limited.

Year	Net Assets	Change
2026-03-31	Rs14.10 Billion ≈ $152.51 Million	+42.44%
2025-03-31	Rs9.90 Billion ≈ $107.07 Million	+14.44%
2024-03-31	Rs8.65 Billion ≈ $93.56 Million	-0.49%
2023-03-31	Rs8.69 Billion ≈ $94.02 Million	-1.62%
2022-03-31	Rs8.84 Billion ≈ $95.57 Million	+23.77%
2021-03-31	Rs7.14 Billion ≈ $77.22 Million	+70.09%
2020-03-31	Rs4.20 Billion ≈ $45.40 Million	-19.61%
2019-03-31	Rs5.22 Billion ≈ $56.47 Million	-9.81%
2018-03-31	Rs5.79 Billion ≈ $62.62 Million	+18.14%
2017-03-31	Rs4.90 Billion ≈ $53.00 Million	+6.89%
2016-03-31	Rs4.59 Billion ≈ $49.59 Million	+120.97%
2015-03-31	Rs2.08 Billion ≈ $22.44 Million	-26.44%
2014-03-31	Rs2.82 Billion ≈ $30.51 Million	-4.70%
2013-03-31	Rs2.96 Billion ≈ $32.01 Million	+34.87%
2012-03-31	Rs2.19 Billion ≈ $23.73 Million	+24.38%
2011-03-31	Rs1.76 Billion ≈ $19.08 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Healthcare Global Enterprises Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs1.49 Billion	11.21%
Other Components	Rs11.83 Billion	88.79%
Total Equity	Rs13.32 Billion	100.00%

Healthcare Global Enterprises Limited Competitors by Market Cap

The table below lists competitors of Healthcare Global Enterprises Limited ranked by their market capitalization.

Company	Market Cap
Horizon Bancorp NASDAQ:HBNC	$992.72 Million
Southside Bancshares, Inc. NYSE:SBSI	$992.81 Million
CBL & Associates Properties Inc NYSE:CBL	$993.50 Million
Verve Therapeutics Inc NASDAQ:VERV	$994.04 Million
Shenzhen Shenbao Industrial Co Ltd SHE:000019	$992.25 Million
Lintes Technology Co Ltd TW:6715	$992.17 Million
Nitratos de Chile SA SN:NITRATOS	$991.87 Million
Burford Capital Ltd NYSE:BUR	$991.61 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Healthcare Global Enterprises Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 9,224,500,000 to 13,319,700,000, a change of 4,095,200,000 (44.4%).
Net income of 137,600,000 contributed positively to equity growth.
New share issuances of 4,488,500,000 increased equity.
Other comprehensive income decreased equity by 202,820,000.
Other factors decreased equity by 328,080,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs137.60 Million	+1.03%
Share Issuances	Rs4.49 Billion	+33.7%
Other Comprehensive Income	Rs-202.82 Million	-1.52%
Other Changes	Rs-328.08 Million	-2.46%
Total Change	Rs-	44.39%

Book Value vs Market Value Analysis

This analysis compares Healthcare Global Enterprises Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 6.62x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 30.35x to 6.62x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2011-03-31	Rs20.26	Rs614.75	x
2012-03-31	Rs25.02	Rs614.75	x
2013-03-31	Rs46.95	Rs614.75	x
2014-03-31	Rs38.41	Rs614.75	x
2015-03-31	Rs24.86	Rs614.75	x
2016-03-31	Rs58.44	Rs614.75	x
2017-03-31	Rs50.80	Rs614.75	x
2018-03-31	Rs59.75	Rs614.75	x
2019-03-31	Rs54.10	Rs614.75	x
2020-03-31	Rs43.06	Rs614.75	x
2021-03-31	Rs61.34	Rs614.75	x
2022-03-31	Rs64.38	Rs614.75	x
2023-03-31	Rs61.59	Rs614.75	x
2024-03-31	Rs58.81	Rs614.75	x
2025-03-31	Rs65.22	Rs614.75	x
2026-03-31	Rs92.93	Rs614.75	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Healthcare Global Enterprises Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 1.03%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.54%
• Asset Turnover: 0.65x
• Equity Multiplier: 2.94x
Recent ROE (1.03%) is above the historical average (-2.85%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	3.68%	2.94%	0.55x	2.27x	Rs-108.06 Million
2012	-1.58%	-1.25%	0.48x	2.61x	Rs-244.54 Million
2013	-3.71%	-3.11%	0.48x	2.50x	Rs-388.54 Million
2014	-13.48%	-7.88%	0.66x	2.61x	Rs-619.30 Million
2015	0.46%	0.16%	0.69x	4.16x	Rs-173.89 Million
2016	-0.34%	-0.25%	0.56x	2.45x	Rs-440.43 Million
2017	5.12%	3.17%	0.57x	2.83x	Rs-210.93 Million
2018	3.98%	2.47%	0.58x	2.80x	Rs-309.87 Million
2019	-5.20%	-2.53%	0.59x	3.47x	Rs-724.62 Million
2020	-27.99%	-9.74%	0.49x	5.91x	Rs-1.45 Billion
2021	-27.75%	-19.09%	0.50x	2.92x	Rs-2.63 Billion
2022	6.17%	3.84%	0.63x	2.55x	Rs-332.96 Million
2023	3.41%	1.73%	0.73x	2.69x	Rs-567.04 Million
2024	5.83%	2.52%	0.71x	3.28x	Rs-344.23 Million
2025	4.81%	2.00%	0.63x	3.84x	Rs-478.35 Million
2026	1.03%	0.54%	0.65x	2.94x	Rs-1.19 Billion

Industry Comparison

This section compares Healthcare Global Enterprises Limited's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $12,358,883,610
Average return on equity (ROE) among peers: 4.55%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Healthcare Global Enterprises Limited (HCG)	Rs14.10 Billion	3.68%	1.78x	$992.60 Million
Apollo Hospitals Enterprise Limited (APOLLOHOSP)	$13.33 Billion	6.41%	0.69x	$13.08 Billion
Aster DM Healthcare Limited (ASTERDM)	$38.34 Billion	3.85%	2.04x	$4.41 Billion
GPT Healthcare Ltd (GPTHEALTH)	$1.01 Billion	7.52%	1.28x	$130.23 Million
Jupiter Life Line Hospitals Limited (JLHL)	$2.88 Billion	17.73%	2.15x	$951.57 Million
Krishna Institute of Medical Sciences Limited (KIMS)	$-1.38 Billion	0.00%	0.00x	$3.42 Billion
Lotus Eye Hospital and Institute Limited (LOTUSEYE)	$493.84 Million	-4.01%	0.14x	$29.88 Million
Max Healthcare Institute Limited (MAXHEALTH)	$10.34 Billion	-2.01%	2.21x	$11.48 Billion
Max India Limited (MAXIND)	$6.37 Billion	-2.53%	0.34x	$95.81 Million
Global Health Limited (MEDANTA)	$39.84 Billion	13.97%	0.48x	$3.66 Billion

About Healthcare Global Enterprises Limited

NSE:HCG India Medical Care Facilities

Market Cap

$992.60 Million

Rs91.78 Billion INR

Market Cap Rank

#9094 Global

#439 in India

Share Price

Rs614.75

Change (1 day)

-1.89%

52-Week Range

Rs521.75 - Rs776.30

All Time High

Rs776.30